Lineage Cell Therapeutics (LCTX) Change in Account Payables (2017)
Lineage Cell Therapeutics (LCTX) posted quarterly Change in Account Payables of $428000.0 for Q3 2017, up 323.76% quarter-over-quarter from $101000.0 in Q2 2017.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Change in Account Payables (2017) Analysis & Trends
Lineage Cell Therapeutics' Change in Account Payables history runs 1 years deep, the most recent figure standing at $428000.0 for Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Lineage Cell Therapeutics | 270.71 Mn | 213.99 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 428,000.00 |
| Jun 30, 2017 | 101,000.00 |
| Mar 31, 2017 | 231,000.00 |